Screening for colorectal cancer

References

• Moller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002; 11(Suppl 1)S1–96
   PubMed Web of Science ®Google Scholar
• Hristova L, Hakama M. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol 1997; 36(Suppl 9)1–60
   PubMedGoogle Scholar
• Storm, H, Engholm, G, Ferlay, J, Langmark, F, Olafsdottir, E, Pukkala, E, et al. NORDCAN: Cancer incidence and mortality in the Nordic countries. Version 2.0. Danish Cancer Society. Copenhagen 2003.
   Google Scholar
• Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med 1974; 67: 451–7
   PubMedGoogle Scholar
• Kronborg O, Fenger C. Clinical evidence for the adenoma-carcinoma sequence. Eur J Cancer Prev 1999; 8(Suppl 1)S73–86
   PubMedGoogle Scholar
• Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem Suppl 1992; 16G: 41–6
   PubMedGoogle Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–67
   PubMed Web of Science ®Google Scholar
• Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472–7
   PubMed Web of Science ®Google Scholar
• Kronborg O, Jørgensen O, Fenger C, Rasmussen M. Randomised study of biennial screening with fecal occult blood test. Results after nine screening rounds. Scand J Gastroenterol 2004; 39: 846–51
   PubMed Web of Science ®Google Scholar
• Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467–71
   PubMed Web of Science ®Google Scholar
• Bond JH. Update on colorectal polyps: management and follow-up surveillance. Endoscopy 2003; 35: S35–40
   PubMedGoogle Scholar
• Jorgensen OD, Kronborg O, Fenger C. A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma Follow-up Study. Scand J Gastroenterol 1995; 30: 686–92
   PubMed Web of Science ®Google Scholar
• IARC. Breast Cancer Screening. IARC Handbooks of Cancer Prevention, Volume 7. IARC Press, Lyon, 2002.
   Google Scholar
• Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997; 16: 1017–29
   PubMed Web of Science ®Google Scholar
• Selby JV, Friedman GD. US Preventive Services Task Force. Sigmoidoscopy in the periodic health examination of asymptomatic adults. JAMA 1989; 261: 594–601
   PubMedGoogle Scholar
• Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999; 34: 414–20
   PubMed Web of Science ®Google Scholar
• Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE. The prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. Cancer 1995; 75: 1869–1873
   Google Scholar
• Painter J, Saunders DB, Bell GD, Williams CB, Pitt R, Bladen J. Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design. Endoscopy 1999; 31: 227–31
   PubMedGoogle Scholar
• Kronborg O. Screening for colorectal cancer in the average-risk population. Sem Colon Rect Surg 2002; 13: 16–30
   Google Scholar
• Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002; 55: 307–14
   PubMed Web of Science ®Google Scholar
• Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994; 29: 468–73
   PubMed Web of Science ®Google Scholar
• Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603–7
   PubMed Web of Science ®Google Scholar
• Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998; 317: 559–65
   PubMed Web of Science ®Google Scholar
• Saito H, Soma Y, Nakajima M, Koeda J, Kawaguchi H, Kakizaki R, et al. A. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol Rep 2000; 7: 815–9
   PubMedGoogle Scholar
• Castiglione G, Grazzini G, Ciatto S. Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening. Br J Cancer 1992; 65: 942–4
   PubMedGoogle Scholar
• Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screening 2003; 10: 117–22
   PubMed Web of Science ®Google Scholar
• Rasmussen M, Fenger C, Kronborg O. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II. Scand J Gastroenterol 2003; 38: 114–8
   PubMed Web of Science ®Google Scholar
• Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years. Scand J Gastroenterol 2003; 38: 635–42
   PubMed Web of Science ®Google Scholar
• Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555–60
   PubMed Web of Science ®Google Scholar
• Ahlquist DA. Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed. BMJ 2000; 321: 254–5
   PubMedGoogle Scholar
• Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365–71
   PubMed Web of Science ®Google Scholar
• UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291–1300
   PubMedGoogle Scholar
• Winawer SJ, Fletcher RH, Miller L, Goodlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594–642
   PubMed Web of Science ®Google Scholar
• Mak T, Lalloo F, Evans DG, Hill J. Molecular stool screening for colorectal cancer. Br J Surg 2004; 91: 790–800
   PubMed Web of Science ®Google Scholar
• Levin B, Smith RA, Feldman GE, Colditz GA, Fletcher RH, Nadel M, et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer 2002; 95: 1618–28
   PubMed Web of Science ®Google Scholar
• UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004; 329: 133
   PubMedGoogle Scholar
• Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screening 2005; 12: 28–32
   PubMed Web of Science ®Google Scholar
• http://europa.eu.int/comm/health/ph_determinants/genetics/keydo_genetics_en.htm
   Google Scholar
• Rozen P, Winawer SJ. Report of the OMED colorectal cancer screening committee meeting, New Orleans, 2004–in collaboration with the IDCA. Eur J Cancer Prev 2004; 13: 461–464
   PubMedGoogle Scholar
• Winawer SJ, Zauber AG, Ho MN, O'Brian MJ, Gottlieb MJ, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977–81
   PubMed Web of Science ®Google Scholar
• Ahlquist DA, Shuber AP. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin Chim Acta 2002; 315: 157–68
   PubMedGoogle Scholar
• Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, et al. Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”–SCORE. J Natl Cancer Inst 2002; 94: 1763–72
   PubMedGoogle Scholar
• Prorok, PC, Andriole, GL, Bresalier, RS, Buys, SS, Chia, D, Crawford, ED, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21((6 Suppl)):273S–309S.
   PubMedGoogle Scholar
• Rasmussen M, Kronborg O, Fenger C, Jorgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. Scand J Gastroenterol 1999; 34: 73–8
   PubMed Web of Science ®Google Scholar
• Blom J, Liden A, Jeppsson B, Holmberg L, Pahlman L. Compliance and findings in a Swedish population screened for colorectal cancer with sigmoidoscopy. Eur J Surg Oncol 2002; 28: 827–31
   PubMedGoogle Scholar
• Brevinge H, Lindholm E, Buntzen S, Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55–56 years’ old population. Int J Colorectal Dis 1997; 12: 291–5
   PubMed Web of Science ®Google Scholar
• Hosokawa O, Shirasaki S, Kaizaki Y, Hayashi H, Douden K, Hattori M. Invasive colorectal cancer detected up to 3 years after a colonoscopy negative for cancer. Endoscopy 2003; 35: 506–10
   PubMedGoogle Scholar
• Leaper M, Johnston MJ, Barclay M, Dobbs BR, Frizelle FA. Reasons for failure to diagnose colorectal carcinoma at colonoscopy. Endoscopy 2004; 36: 499–503
   PubMed Web of Science ®Google Scholar
• Harewood GC, Wiersema MJ, Melton LJ, 3rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186–94
   PubMedGoogle Scholar
• Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191–200
   PubMed Web of Science ®Google Scholar
• Atkin W, Rogers P, Cardwell C, Cook C, Cuzick J, Wardle J, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology 2004; 126: 1247–56
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Skovlund E, Grotmol T, Thiis-Evensen E, Gondol G, Huppertz-Hauss G, et al. Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer. Scand J Gastroenterol 2003; 38: 1268–74
   PubMed Web of Science ®Google Scholar
• Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000; 95: 868–77
   PubMed Web of Science ®Google Scholar
• Butruk E, Regula J, Polkowski M, Rupinski M, Przytulski K, et al. National colorectal cancer screening programme in Poland. Endoscopy 2002; 34: 939–40
   Google Scholar
• Dulai GS, Farmer MM, Ganz PA, Bernaards CA, Qi K, Dietrich AJ, et al. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting. Cancer 2004; 100: 1843–52
   PubMed Web of Science ®Google Scholar
• Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993; 88: 825–31
   PubMed Web of Science ®Google Scholar
• Hoff G. CRC screening: Review of the evidence and suggestions on when and how to move on from randomised trials to screening programmes. Scand J Gastroenterol 2004; 39: 99–103
   PubMed Web of Science ®Google Scholar
• Towler, BP, Irwing, L, Glasziou, P, Weller, D, Kewenter, J. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. The Cochrane Database of Systematic Reviews 1998, Issue 2. Art. No.: CD001216. (DOI:10.1002/14651858.CD001216).
   Google Scholar
• Hoff, G (2004) , Blanchard, J, Crespi, M, Faulds Wood, L, Keighley, M, Lamy, V, et al. Public Awareness and Lobbying: Group 3 Report. ESGE/UEGF Colorectal Cancer–Public Awareness Campaign. The Public/Professional Interface Workshop: OsloNorway, June, 20–22, 2003. Endoscopy;36:359–61.
   Google Scholar
• Bowles CJ, Leicester R, Romaya C, Swarbrick E, Williams CB, Epstein O. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow?. Gut 2004; 53: 277–83
   PubMed Web of Science ®Google Scholar
• Ristikankare M, Hartikainen J, Heikkinen M, Janatuinen E, Julkunen R. Is routinely given conscious sedation of benefit during colonoscopy?. Gastrointest Endosc 1999; 49: 566–72
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Hoff G, Severinsen H, Erga J, Sauar J, Huppertz-Hauss G. Systematic quality control programme for colonoscopy in an endoscopy centre in Norway]. Tidsskr Nor Laegeforen 2004; 124: 1402–5
   PubMedGoogle Scholar
• Geul KW, Bosman FT, van Blankenstein M, Grobbee DE, Wilson JH. Prevention of colorectal cancer. Costs and effectiveness of sigmoidoscopy. Scand J Gastroenterol Suppl 1997; 223: 79–87
   PubMedGoogle Scholar
• Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995; 109: 1781–90
   PubMed Web of Science ®Google Scholar
• Rex DK, Imperiale TF, Portish V. Patients willing to try colonoscopy without sedation: associated clinical factors and results of a randomized controlled trial. Gastrointest Endosc 1999; 49: 554–9
   PubMed Web of Science ®Google Scholar
• Whynes DK. Cost-effectiveness of screening for colorectal cancer: evidence from the Nottingham faecal occult blood trial. J Med Screen 2004; 11: 11–5
   PubMedGoogle Scholar
• Ramsey SD, Mandelson MT, Berry K, Etzioni R, Harrison R. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 2003; 125: 1645–50
   PubMed Web of Science ®Google Scholar
• Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572–5
   PubMed Web of Science ®Google Scholar
• Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995; 155: 1741–8
   PubMed Web of Science ®Google Scholar
• Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995; 123: 904–10
   PubMed Web of Science ®Google Scholar
• Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343: 162–8
   PubMed Web of Science ®Google Scholar
• Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63–72 years. Gut 1999; 45: 834–9
   PubMed Web of Science ®Google Scholar
• Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100: 64–7
   PubMed Web of Science ®Google Scholar